Head_Type,Head_Entity,Relation,Tail_Type,Tail_Entity,Description
Drug_Formulation,coated formulations,tested_in,Clinical_Test,ethanol release studies,涂层剂型在乙醇释放研究中测试
Clinical_Test,once-weekly oral memantine,has_pharmacokinetics,Biomarker,near-linear drug release over seven days,一周一次口服美金刚制剂具有近线性药物释放特征
Drug_Release,drug release,measured_by,Clinical_Test,in vitro release assay,药物释放通过体外释放试验测量
Clinical_Test,ethanol release studies,measures,Drug_Release,drug release in ethanol,乙醇释放研究测量乙醇中的药物释放
Clinical_Test,PK evaluation,compares,Treatment,coated vs uncoated dosage forms,药代动力学评估比较涂层与未涂层剂型
Clinical_Test,once-weekly oral memantine,has_pharmacokinetics,Biomarker,resistance to dose dumping,一周一次口服美金刚制剂具有抗剂量倾泻特性
Material,simulated gastric fluid,maintains,Condition,sink conditions,模拟胃液维持沉没条件
Clinical_Test,once-weekly oral memantine,achieves,Biomarker,7-day gastric retention,一周一次口服美金刚制剂实现7天胃滞留
Drug_Release,drug release in ethanol,compared_to,Drug_Release,drug release in FaSSGF,乙醇中的药物释放与FaSSGF中的药物释放比较
Clinical_Test,accurate drug release measurement,achieved_by,Method,replacing release media,准确的药物释放测量通过更换释放介质实现
Disease,Alzheimer's disease,treated_by,Treatment,memantine hydrochloride,美金刚盐酸盐用于治疗阿尔茨海默病
Condition,sink conditions,ensures,Clinical_Test,accurate drug release measurement,沉没条件确保准确的药物释放测量
Biomarker,memantine,administered_in,Drug_Formulation,gastro-retentive dosage form,美金刚通过胃滞留剂型给药
Clinical_Test,once-weekly oral memantine,has_release_kinetics,Biomarker,near zero-order kinetics,一周一次口服美金刚制剂具有近零级释放动力学
Imaging_Method,X-ray,monitors,Clinical_Test,gastric retention,X射线用于监测胃滞留情况
Structure,drug-loaded arms,controls,Drug_Release,drug release,载药臂控制药物释放
Imaging_Method,X-ray,confirms,Event,complete passage,X射线确认完全通过事件
Disease,Alzheimer's disease,treated_by,Treatment,memantine,美金刚用于治疗阿尔茨海默病
Method,replacing release media,performed_at,Time_Point,each time point,更换释放介质在每个时间点进行
Clinical_Test,once-weekly oral memantine,has_pharmacokinetics,Biomarker,biocompatible and chemically stable polymer matrix,一周一次口服美金刚制剂采用生物相容且化学稳定的聚合物基质
Material,ethylcellulose,resists,Risk_Factor,ethanol,乙基纤维素抵抗乙醇影响
Clinical_Test,once-weekly oral memantine,has_formulation_method,Research_Method,stellate design,一周一次口服美金刚制剂采用星形设计
Drug,memantine HCl,blended_with,Material,polycaprolactone,盐酸美金刚与聚己内酯混合
Drug_Formulation,gastro-retentive dosage form,breaks_down_into,Material,smaller components,胃滞留剂型分解为较小组件
Drug_Release,drug release in FaSSGF,measured_over,Time_Period,7 days,FaSSGF中的药物释放在7天内测量
Drug_Release,drug release profile,analyzed_by,Method,scanning electron microscopy,药物释放曲线通过扫描电子显微镜分析
Imaging_Method,X-ray,detects,Clinical_Manifestation,gastric retention,X射线成像用于检测胃内滞留情况
Risk_Factor,ethanol,challenges,Drug_Formulation,coated formulations,乙醇挑战涂层剂型
Clinical_Test,once-weekly oral memantine,has_pharmacokinetics,Biomarker,modulated release profile by water-soluble excipients,一周一次口服美金刚制剂通过水溶性辅料调节释放曲线
Treatment,memantine hydrochloride,has_risk,Clinical_Manifestation,discontinuation rates,美金刚盐酸盐治疗存在停药率高的风险
Treatment,memantine,released_from,Drug_Formulation,polymer matrix,美金刚从聚合物基质中释放
Treatment,memantine,has_formulation,Clinical_Test,once-weekly oral memantine,美金刚有一周一次的口服制剂
Treatment,LYN-057,has_property,Clinical_Manifestation,controlled and sustained release,LYN-057具有控释和持续释放的特性
Clinical_Test,HPLC,detects,Biomarker,memantine,高效液相色谱法检测美金刚
Time_Point,each time point,determines,Clinical_Test,drug release rate,每个时间点确定药物释放速率
Treatment,memantine hydrochloride,has_form,Treatment,LYN-057,美金刚盐酸盐的长效口服剂型为LYN-057
Clinical_Test,once-weekly oral memantine,has_pharmacokinetics,Biomarker,consistent 7-day gastric retention in dog model,一周一次口服美金刚制剂在狗模型中实现一致的7天胃滞留
Body_Part,stomach,monitored_by,Imaging_Method,X-ray,胃通过X射线监测
Material,memantine-polymer formulation,shows,Pathological_Change,cross section,美金刚-聚合物配方显示横截面
Clinical_Test,gastric retention,assessed_by,Imaging_Method,X-ray,胃滞留通过X射线评估
Material,smaller components,passes_through,Body_Part,lower GI tract,较小组件通过下消化道排出
Method,pharmacokinetic modelling,estimates,Parameter,rate of drug absorption,药代动力学模型估计药物吸收速率
Event,complete passage,marks,Time_Point,end of gastric retention,完全通过标记胃滞留结束时间点
Parameter,rate of drug absorption,depends_on,Factor,drug release rate,药物吸收速率取决于药物释放速率
Treatment,memantine,administered_in,Drug_Formulation,gastro-retentive dosage form,美金刚通过胃滞留剂型给药
Time_Point,end of gastric retention,determined_by,Imaging_Method,X-ray,胃滞留结束时间点通过X射线确定
Time_Point,1 hour,marks,Event,ethanol challenge,1小时标记乙醇挑战事件
Pathological_Change,cross section,reveals,Structure,drug-loaded arms,横截面揭示载药臂结构
Imaging_Method,X-ray,images,Body_Part,stomach,X射线成像胃
Material,coating polymers,include,Material,Eudragit RS,涂层聚合物包括Eudragit RS
Treatment,memantine,quantified_by,Clinical_Test,HPLC,美金刚通过高效液相色谱法量化
Material,Poloxamer P407,affects,Drug_Release,drug release rate,Poloxamer P407影响药物释放速率
Clinical_Test,in vitro release assay,uses,Material,simulated gastric fluid,体外释放试验使用模拟胃液
Material,memantine HCl formulations,composed_of,Material,polycaprolactone,盐酸美金刚配方由聚己内酯组成
Coating,thin polymer coating,resists,Risk_Factor,ethanol,薄聚合物涂层抵抗乙醇影响
Clinical_Test,LC-MS/MS,quantifies,Biomarker,memantine,液相色谱-质谱联用法量化美金刚
Clinical_Test,once-weekly oral memantine,has_pharmacokinetics,Biomarker,robust and consistent controlled drug release,一周一次口服美金刚制剂具有稳健且一致的药物释放控制
Clinical_Test,once-weekly oral memantine,has_pharmacokinetics,Biomarker,resistance to gastric migratory motor complex,一周一次口服美金刚制剂具有抗胃迁移运动复合体的特性
Drug_Release,drug release rate,measured_by,Clinical_Test,in vitro release assay,药物释放速率通过体外释放试验测量
Drug_Release,drug release,tuned_by,Material,soluble excipients,药物释放通过可溶性赋形剂调节
Treatment,memantine hydrochloride,has_effect,Clinical_Manifestation,steady state concentrations,美金刚盐酸盐能够达到稳态血药浓度
Factor,drug release rate,affected_by,Material,coating polymers,药物释放速率受涂层聚合物影响
Clinical_Test,plasma concentration,determined_by,Clinical_Test,LC-MS/MS,血浆浓度通过液相色谱-质谱联用法确定
Event,ethanol challenge,affects,Drug_Release,drug release profile,乙醇挑战影响药物释放曲线
Clinical_Test,drug release rate,calculated_by,Method,pharmacokinetic modelling,药物释放速率通过药代动力学模型计算
Drug_Formulation,gastro-retentive dosage form,composed_of,Material,stellate arms,胃滞留剂型由星形臂组成
Method,dip coating,creates,Coating,thin polymer coating,浸涂法形成薄聚合物涂层
Material,polycaprolactone,blended_with,Material,memantine HCl,聚己内酯与盐酸美金刚混合
Clinical_Test,once-weekly oral memantine,has_pharmacokinetics,Biomarker,scalable production methods,一周一次口服美金刚制剂采用可扩展的生产方法
Clinical_Test,once-weekly oral memantine,has_bioavailability,Biomarker,100% relative bioavailability,一周一次口服美金刚制剂具有100%相对生物利用度
Time_Period,7 days,includes,Time_Point,1 hour,7天包括1小时
Imaging_Method,X-ray,tracks,Drug_Formulation,gastro-retentive dosage form,X射线跟踪胃滞留剂型
Treatment,memantine hydrochloride,has_effect,Clinical_Manifestation,continuous seven day exposure,美金刚盐酸盐能够实现连续七天的药物暴露
Clinical_Test,once-weekly oral memantine,has_pharmacokinetics,Biomarker,tunable profiles,一周一次口服美金刚制剂具有可调节的药代动力学特征
Clinical_Test,in vitro release assay,performed_on,Material,memantine HCl formulations,体外释放试验在盐酸美金刚配方上进行
Treatment,memantine,has_pharmacokinetics,Biomarker,sustained plasma levels,美金刚制剂具有持续的血浆药物浓度
Drug_Formulation,gastro-retentive dosage form,retained_in,Body_Part,stomach,胃滞留剂型在胃中滞留
Treatment,Namenda XR,has_property,Clinical_Manifestation,extended release,Namenda XR具有缓释特性
Clinical_Test,PK study,evaluates,Treatment,memantine hydrochloride,药代动力学研究用于评估美金刚盐酸盐的释放特性
Material,dosage form components,monitored_by,Imaging_Method,X-ray,剂型组件通过X射线监测
Body_Part,lower GI tract,clears,Material,dosage form components,下消化道清除剂型组件
Treatment,memantine hydrochloride,has_form,Treatment,Namenda XR,美金刚盐酸盐的缓释剂型为Namenda XR
Biomarker,memantine,measured_in,Clinical_Test,plasma concentration,美金刚在血浆浓度中测量
Material,stellate arms,contains,Drug,memantine HCl,星形臂含有盐酸美金刚
Treatment,memantine,improves,Clinical_Manifestation,medication adherence,美金刚制剂提高药物依从性
Risk_Factor,ethanol,affects,Drug_Release,drug release,乙醇影响药物释放
Treatment,coated dosage form,resists,Risk_Factor,ethanol,涂层剂型抵抗乙醇影响
Material,polycaprolactone,coated_with,Material,ethylcellulose,聚己内酯涂有乙基纤维素
Method,scanning electron microscopy,images,Material,memantine-polymer formulation,扫描电子显微镜成像美金刚-聚合物配方
Material,memantine HCl,quantified_by,Clinical_Test,HPLC,盐酸美金刚通过高效液相色谱法量化
Clinical_Test,once-weekly oral memantine,has_pharmacokinetics,Biomarker,sustained plasma levels over seven days,一周一次口服美金刚制剂具有持续7天的血浆药物浓度
Material,Eudragit RS,applied_by,Method,dip coating,Eudragit RS通过浸涂法应用
Body_Part,stomach,contains,Drug_Formulation,gastro-retentive dosage form,
Material,soluble excipients,include,Material,Poloxamer P407,可溶性赋形剂包括Poloxamer P407
Clinical_Test,once-weekly oral memantine,has_pharmacokinetics,Biomarker,therapeutic blood levels in humans,一周一次口服美金刚制剂在人体内维持治疗血药浓度
